SCHEMBL14313093

SCHEMBL14313093

Cc1nc(-c2nc(Cl)cs2)ncc1OC(=O)Nn1cc(C(F)F)c2ccncc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14313407 0.94 HPGDS (0.30) —
SCHEMBL14312827 0.93 PTGER1 (0.30) —
SCHEMBL14312836 0.93 TGFBR1 (0.32) —
SCHEMBL14313305 0.90 HPGDS (0.33) —
SCHEMBL14312659 0.89 HPGDS (0.34) —
SCHEMBL14313243 0.89 MAPK8 (0.30) —
SCHEMBL14313450 0.88 — —
SCHEMBL14313038 0.88 HPGDS (0.35) —
SCHEMBL14312676 0.86 TGFBR1 (0.32) —
SCHEMBL14312784 0.86 NTRK1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2142516-B1 PYRIMIDINE HYDRAZIDE COMPOUNDS AS PGDS INHIBITORS SANOFI SA (FR) 2012-12-26 — — EP claimed
Send feedback